Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Roche's Genentech unit has started work on a $700 million manufacturing facility in North Carolina, part of a promised $50 billion investment in the US. The plant – its first on the East Coast of the ...

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...